{'fraction_non_alphanumeric': 0.05574912891986063, 'fraction_numerical': 0.050522648083623695, 'mean_word_length': 4.6048780487804875, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 1, 'zh_pornsignals.json': 0}}
Therapeutic and prognostic considerations in primary carcinoma of the vagina

We analyzed 46 patients with primary carcinoma of the vagina treated between 1969 and 1990. Median age of the patients was 67 years (range 33‐89 years). Most (52%) of them were obese and 35% were nulliparous. Four (9%) had suffered from other gynecologic carcinoma and had been operated six to 23 years before the current carcinoma. Forty (87%) patients had squamous cell carcinoma. Stage 0 (carcinoma in situ) was found in three (7%) cases and stage I IV in 21 (54%), 10 (22%). four (9%) and eight (17%,) cases, respectively. Most (81%) of the patients were treated with radiotherapy (alone or in combination with other treatments): combination of brachytherapy and external radiotherapy were used in 45% of the cases. Surgery was used in all stage 0 cases and in 52% of stage I cases. Recurrence of the disease was found in 20 (43%) cases during the follow‐up of 10 years. Most often (40%) site of the recurrence was the vagina. Both 5‐ and 10‐year survival were 38%. Stage and extent of the tumor were independent prognostic factors in stepwise multivariate analysis.